How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

524 results for

Saint Louis University Mental Status

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. MCI: CPAP Treatment of OSA (Memories2)

Recruiting Saint Louis, Missouri, United States, 63130-4862 Contact: Brandye Mazdra 314-566-7038 Principal Investigator: Luqi Chi, MD United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Grace Nathanson 215-746-7465 Principal Investigator: Nalaka Gooneratne, MD United States, Texas University of Texas at Austin Recruiting Austin, Texas, United States, 78701 Contact: Maegen Mackenzie, RN 512-471-9462 Principal Investigator: Kathy (...) validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03113461 Recruitment Status : Recruiting First Posted : April 13, 2017 Last Update Posted : April 18, 2018 See Sponsor: University of Pennsylvania Collaborator: National Institute on Aging (NIA

2017 Clinical Trials

142. Study of the Relay Pro® Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta

, Indiana, United States, 46202 Principal Investigator: Joel Corvera, MD United States, Iowa University of Iowa Hospital and Clinic Recruiting Iowa City, Iowa, United States, 52242 Principal Investigator: Melhem Sharafuddin, MD United States, Massachusetts Beth Israel Deaconess Medical Center / Harvard Medical School Recruiting Boston, Massachusetts, United States, 02215 Principal Investigator: Marc Schermerhorn, MD United States, Missouri St. Louis University Not yet recruiting Saint Louis, Missouri (...) Identifier: NCT03090230 Recruitment Status : Recruiting First Posted : March 24, 2017 Last Update Posted : February 23, 2018 See Sponsor: Bolton Medical Information provided by (Responsible Party): Bolton Medical Study Details Study Description Go to Brief Summary: The purpose of this study is to investigate the safety and effectiveness of the RelayPro Thoracic Stent-Grafts in subjects with traumatic injury of the descending thoracic aorta (DTA) Condition or disease Intervention/treatment Phase Other

2017 Clinical Trials

143. A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder

Brothers Behavioral Health Hospital Hoffman Estates, Illinois, United States, 60169 United States, Massachusetts Boston Clinical Trials Boston, Massachusetts, United States, 02131 United States, Missouri Midwest Research Group - St. Charles Psychiatric Associates Saint Charles, Missouri, United States, 63304 St. Louis Clinical Trials Saint Louis, Missouri, United States, 63141 United States, New Jersey Hassman Research Institute Berlin, New Jersey, United States, 08009 Global Medical Institutes (...) studies (100). Please remove one or more studies before adding more. A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03093025 Recruitment Status : Terminated (Sponsor decision) First Posted

2017 Clinical Trials

144. Psychosocial Factors of Burn Related Injuries and Perceived Gaps in Service Delivery

Update Posted : May 16, 2018 See Sponsor: St. Louis University Collaborator: Mercy Research Information provided by (Responsible Party): Anne Farina MSW, LCSW, St. Louis University Study Details Study Description Go to Brief Summary: This study will utilize a mixed methods design featuring quantitative assessment of symptoms in conjunction with collecting in-depth qualitative data. In this study, perceived stress, mental health symptoms and behaviors and other variables will be used to test how (...) may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03094013 Contacts Layout table for location contacts Contact: Anne Farina 314-719-7771 Locations Layout table for location information United States, Missouri Mercy Hospital Recruiting Saint Louis, Missouri, United States, 63141 Contact: Jonathan Pollack, MD 314-251-5570 Sponsors and Collaborators St. Louis University Mercy

2017 Clinical Trials

145. What Matters Most: Choosing the Right Breast Cancer Surgery for You

ClinicalTrials.gov identifier (NCT number): NCT03136367 Locations Layout table for location information United States, Missouri Washington University in St. Louis Saint Louis, Missouri, United States, 63110 United States, New Hampshire Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 Bellevue Hospital Center New York, New York, United States, 10016 NYU Langone (...) : Choosing the Right Breast Cancer Surgery for You The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03136367 Recruitment Status : Active, not recruiting First Posted : May 2, 2017 Last Update Posted : March 6, 2019 Sponsor: Dartmouth-Hitchcock Medical Center Collaborators: Washington University School

2017 Clinical Trials

146. The ReNEW Study: Maestro® New Enrollment Post-Approval Study Protocol

Layout table for location information United States, Arizona HonorHealth Recruiting Scottsdale, Arizona, United States, 85258 Contact: Heather Lane 480-323-3000 Principal Investigator: James Swain, MD United States, California Smart Dimensions Weight Loss Recruiting Fountain Valley, California, United States, 92708 Contact: Richard Hoang, PA 714-861-4666 Principal Investigator: Peter C LePort, MD United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United (...) : Maestro® New Enrollment Post-Approval Study Protocol (ReNEW) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03145636 Recruitment Status : Recruiting First Posted : May 9, 2017 Last Update Posted : February 15, 2018 See

2017 Clinical Trials

147. [Trial of device that is not approved or cleared by the U.S. FDA]

, 20815 United States, Missouri Clayton Sleep Institute Saint Louis, Missouri, United States, 63143 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Sponsors and Collaborators Philips Respironics Study Documents (Full-Text) Documents provided by Philips Respironics: [PDF] September 18, 2017 More Information Go to Layout table for additonal information Responsible Party: Philips Respironics ClinicalTrials.gov Identifier: Other Study ID Numbers: AI (...) of the Effectiveness and Efficacy of the PowerSleep Device The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03162328 Recruitment Status : Completed First Posted : May 22, 2017 Results First Posted : January 29, 2019 Last Update Posted : January 29, 2019 Sponsor: Philips Respironics Information provided

2017 Clinical Trials

148. Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization

: NCT03182166 Recruitment Status : Recruiting First Posted : June 9, 2017 Last Update Posted : November 27, 2018 See Sponsor: Centre Hospitalier Universitaire de Saint Etienne Collaborator: Merck Sharp & Dohme Corp. Information provided by (Responsible Party): Centre Hospitalier Universitaire de Saint Etienne Study Details Study Description Go to Brief Summary: It is planned to enroll 80 UC patients who will require optimization of golimumab after secondary LOR. The review of the study protocol and its (...) approval by an Independent Ethics Committee of the University of Saint Etienne are pending. All patients enrolled will give their written informed consent before being included. This study will be conducted in accordance with the ethical principles that have their origins in the Declaration of Helsinki, in compliance with the approved protocol, good clinical practice and applicable regulatory requirements. Patients will visit the investigator from screening visit to visit 6 at W-1, W0, W2, W4, W8

2017 Clinical Trials

149. OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

. United States, Minnesota Mayo Clinic-Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Maureen Lemens, MD 507-293-1487 Principal Investigator: Carrie Langstraat, MD United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63108 Contact: Research Coordinator 314-362-2288 Principal Investigator: Premal Thaker, M.D United States, Ohio Kettering Medical Center Recruiting Kettering, Ohio, United States, 45427 Contact: Allison (...) . OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03180307 Recruitment Status : Recruiting First Posted : June 8, 2017 Last Update Posted

2017 Clinical Trials

150. Study of AMV564 in Patients With AML

, Illinois Northwestern Recruiting Chicago, Illinois, United States, 60611 Contact: Study Coordinator 312-695-1301 United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 United States, New York Weill Cornell Medical College, The New York Presbyterian Hospital Recruiting New York, New York, United States, 10021 United States, Ohio The Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact (...) serious underlying medical or psychiatric condition (e.g. alcohol or drug abuse), dementia or altered mental status or any issue that would impair the ability of the patient to understand informed consent or that in the opinion of the investigator would contraindicate the patient's participation in the study or confound the results of the study. Ability to become pregnant. However, female patients who have a negative serum or urine pregnancy test before enrollment and agree to use two highly effective

2017 Clinical Trials

151. Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies

, Kentucky, United States, 40504 United States, Maryland Mid-Atlantic Epilepsy and Sleep Center Bethesda, Maryland, United States, 20817 United States, Missouri The Comprehensive Epilepsy Care Center for Children and Adults Saint Louis, Missouri, United States, 63131 United States, New Jersey Northeast Regional Epilepsy Group Hackensack, New Jersey, United States, 07601 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 United States, South Carolina (...) studies (100). Please remove one or more studies before adding more. Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03166215 Recruitment Status : Completed First Posted : May 25, 2017 Last

2017 Clinical Trials

152. Helping Poor Smokers Quit

): NCT03194958 Contacts Layout table for location contacts Contact: Christina D Roberts, MPH 314-935-2721 Locations Layout table for location information United States, Missouri Washington University in St. Louis Recruiting Saint Louis, Missouri, United States, 63130 Contact: Matthew Kreuter, PhD 314-935-3701 Contact: Amy McQueen, PhD 314-935-3715 Sponsors and Collaborators Washington University School of Medicine National Institutes of Health (NIH) National Cancer Institute (NCI) Investigators Layout table (...) of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03194958 Recruitment Status : Recruiting First Posted : June 21, 2017 Last Update Posted : July 26, 2018 See Sponsor: Washington University School of Medicine Collaborators: National Institutes of Health (NIH) National Cancer Institute (NCI

2017 Clinical Trials

153. PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery

information United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Ryan C Guffey, M.D. 314-286-2883 Principal Investigator: Ryan C Guffey, M.D. Sub-Investigator: Mitchell E Fingerman, M.D. Sub-Investigator: Erin Gibbons, M.D. Sub-Investigator: Susan Ironstone, M.D. Sub-Investigator: Arbi Ben Abdallah Sub-Investigator: Rebecca L Aft, M.D. Sub-Investigator: Amy E Cyr, M.D. Sub-Investigator: Julie A Margenthaler, M.D. Sub-Investigator (...) Status : Recruiting First Posted : March 21, 2017 Last Update Posted : January 8, 2019 See Sponsor: Washington University School of Medicine Information provided by (Responsible Party): Washington University School of Medicine Study Details Study Description Go to Brief Summary: In this double blinded randomized placebo-controlled trial, 160 subjects scheduled for breast surgery involving the axilla will be administered a multimodal pain regimen including acetaminophen, dexamethasone, celecoxib

2017 Clinical Trials

154. A Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients

using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03207906 Locations Layout table for location information United States, California Compassionate Cancer Care Fountain Valley, California, United States, 92708 United States, Illinois Northwestern University Department of Dermatology Chicago, Illinois, United States, 60611 United States, Missouri Washington University Saint Louis, Missouri, United States, 63130 (...) . Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03207906 Recruitment Status : Completed First Posted : July 5, 2017 Last Update Posted : January 25, 2019 Sponsor: Veloce BioPharma LLC Information provided by (Responsible Party): Veloce BioPharma LLC Study Details Study Description Go to Brief Summary: Paronychia is inflammation of the skin surrounding the nail that leads to secondary infection. Iatrogenic paronychia has been clearly associated with cancer chemotherapies

2017 Clinical Trials

155. Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System

Not yet recruiting Boston, Massachusetts, United States, 02114 Principal Investigator: Matthew Eagleton, MD United States, Missouri Barnes Jewish Hospital at Washington University Recruiting Saint Louis, Missouri, United States, 63110 Principal Investigator: Luis Sanchez, MD United States, Ohio Cleveland Clinic Not yet recruiting Cleveland, Ohio, United States, 44195 Principal Investigator: Eric Roselli, MD United States, Pennsylvania Hospital of the University of Pennsylvania/Penn Presbyterian (...) Feasibility Study of the RelayBranch Thoracic Stent-Graft System (RelayBranch) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03214601 Recruitment Status : Recruiting First Posted : July 11, 2017 Last Update Posted : February

2017 Clinical Trials

156. Outcomes of Purpura FULminans in Adults

University Hospital Lilles, France, 59000 Edouard Herriot Hospital Lyon, France, 69003 Melun Hospital Melun, France, 77000 Nice University Hospital Nice, France, 6003 Orléans Hospital Orléans, France, 45000 Saint Louis Hospital Paris, France, 75010 Saint-Antoine Hospital Paris, France, 75012 Pitié-Salpétrière Hospital Paris, France, 75013 Cochin Hospital Paris, France, 75014 Bichat University Hospital Paris, France, 75018 Poissy Hospital Poissy, France, 78300 Poitiers University Hospital Poitiers, France (...) Study (hOPeFUL) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03216577 Recruitment Status : Completed First Posted : July 13, 2017 Last Update Posted : March 9, 2018 Sponsor: Henri Mondor University Hospital Collaborator: Fondation de France Information provided by (Responsible Party): Nicolas de

2017 Clinical Trials

157. Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas

Ullrich, MD, PhD Sub-Investigator: Scott Plotkin, MD Sub-Investigator: Mark Kieran, MD, PhD United States, Missouri Washington University School of Medicine Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: David Gutmann, MD, PhD 314-362-7379 Contact: Bruna Lluka 314-286-1728 Principal Investigator: David Gutman, MD, PhD United States, New York New York University Medical Center Recruiting New York, New York, United States, 10016 Contact: Jeffrey Allen, MD 212-263-9907 Contact (...) adding more. Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas (NF108-BINI) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03231306 Recruitment Status : Recruiting First Posted : July

2017 Clinical Trials

158. Communicating Multiple Disease Risks: A Translation of Risk Prediction Science

for location information United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Sponsors and Collaborators Washington University School of Medicine Investigators Layout table for investigator information Principal Investigator: Erika Waters, MPH, Ph.D. Washington University School of Medicine More Information Go to Additional Information: Layout table for additonal information Responsible Party: Washington University School of Medicine (...) . Communicating Multiple Disease Risks: A Translation of Risk Prediction Science The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03255291 Recruitment Status : Completed First Posted : August 21, 2017 Last Update Posted : January 9, 2019 Sponsor: Washington University School of Medicine Information provided

2017 Clinical Trials

159. Text Based Mobile Technology and Weight Loss

University in St. Louis Saint Louis, Missouri, United States, 63105 Sponsors and Collaborators Washington University School of Medicine Investigators Layout table for investigator information Principal Investigator: Diana Parra Washington University School of Medicine More Information Go to Layout table for additonal information Responsible Party: Washington University School of Medicine ClinicalTrials.gov Identifier: Other Study ID Numbers: 201704048 First Posted: June 29, 2017 Last Update Posted (...) and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03203655 Recruitment Status : Completed First Posted : June 29, 2017 Last Update Posted : February 15, 2019 Sponsor: Washington University School of Medicine Information provided by (Responsible Party): Washington University School of Medicine Study Details Study

2017 Clinical Trials

160. Prescribing Exercise as Medicine in Pregnancy

and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03239054 Recruitment Status : Withdrawn (IRB issues) First Posted : August 3, 2017 Last Update Posted : August 2, 2018 Sponsor: St. Louis University Information provided by (Responsible Party): Shilpa Babbar, MD, St. Louis University Study Details Study Description Go (...) (NCT number): NCT03239054 Locations Layout table for location information United States, Missouri St. Mary's Health Center Saint Louis, Missouri, United States, 63117 Sponsors and Collaborators St. Louis University Investigators Layout table for investigator information Principal Investigator: Shilpa Babbar, MD St. Louis University More Information Go to Layout table for additonal information Responsible Party: Shilpa Babbar, MD, Principal Investigator, St. Louis University ClinicalTrials.gov

2017 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>